Virtual doppelgangers could one day revolutionize medicine: Empa researchers are developing a digital twin, which should facilitate the development of personalized therapies. The goal is for these avatars to demonstrate how ...
Jul 15, 2019
0
0
An artificial heart would be an absolute lifesaver for people with cardiac failure. However, to recreate the complex organ in the laboratory, one would first need to work out how to grow multi-layered, living tissues. Researchers ...
Nov 7, 2017
0
2
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating arthritis. This is based on a polysaccharide, a long-chain sugar molecule, originating from brown algae. ...
Aug 23, 2017
0
1129
An Empa team has succeeded in developing a new three-dimensional cell model of the human placental barrier. The "model organ" can quickly and reliably deliver new information on the intake of substances, such as nano-particles, ...
Aug 8, 2017
0
0
Ten million people in Europe alone suffer from cardiac insufficiency, or a weak heart. One day, many of them may require a heart transplant. Artificial heart pumps are frequently used to bridge the wait for the transplant. ...
May 5, 2017
0
0
The characteristics of human skin are heavily dependent on the hydration of the tissue - in simple terms, the water content. This also changes its interaction with textiles. Up to now, it has only been possible to determine ...
Apr 19, 2017
0
3
Thanks to a collaboration with the Balgrist University Hospital and University of Pittsburgh, Empa is beginning to decode the mechanics of the lower vertebrae. Researchers would like be able to reveal how wear and tear comes ...
Apr 22, 2015
0
20
Artificial joints have a limited lifespan. After a few years, many hip and knee joints have to be replaced. Much more complex are intervertebral disc implants, which cannot easily be replaced after their "expiry date" and ...
May 29, 2014
0
0
The latest Empa "Technology Briefing" took place at the end of April in St Gallen, dealing with the the treatment and prevention of chronic sores. Specialists from healthcare sector, science and the med-tech industry used ...
May 26, 2014
0
0
The concept is amazing: a synthetic cell carrier is populated by skin cells and dissolves simultaneously. In just two years, the Lucerne-based company nolax and Empa have developed this project up to a first proof of concept ...
Sep 2, 2013
0
0
